Literature DB >> 7285366

Phospholipids and microviscosity study in broncho-alveolar lavage fluids from control subjects and from patients with extrinsic allergic alveolitis.

P Jouanel, C Motta, J Brun, C Molina, B Dastugue.   

Abstract

Bronchoalveolar lavages were studied in control subjects and patients with extrinsic allergic alveolitis. Phospholipids, fatty acid composition of the different phospholipid species found and cholesterol were investigated. In allergic alveolitis, the phosphatidylcholine was absent, whereas two usually minor components in lung surfactant, phosphatidylethanolamine and phosphatidylinositol, were considerably enhanced. The tensio-active properties of the phospholipids present in fluids were investigated by a fluorescence polarization technique. Microviscosity of the phospholipids was studied, using 1,6-diphenyl-1,3,5-hexatriene. High values for the microviscosity were encountered in samples from patients. Phosphatidylethanolamine present at a high level exhibits the highest microviscosity. Saturated fatty acids in phospholipids and cholesterol are rigidifying factors contributing to the high microviscosity values found in allergic alveolitis. Moreover, one very important point microviscosity values found in allergic alveolitis. Moreover, one very important point brought out by the this technique is its full independence from the fluid volume recovery.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7285366     DOI: 10.1016/0009-8981(81)90077-2

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  5 in total

1.  Proceedings of the British Thoracic Society. 1986 winter meeting. 11-12 December 1986, London. Abstracts.

Authors: 
Journal:  Thorax       Date:  1987-03       Impact factor: 9.139

2.  Enhancement of the antigen-presenting function of monocytes by cholesterol: possible relevance to inflammatory mechanisms in extrinsic allergic alveolitis and atherosclerosis.

Authors:  D A Hughes; P J Townsend; P L Haslam
Journal:  Clin Exp Immunol       Date:  1992-02       Impact factor: 4.330

3.  Immunoregulatory properties of pulmonary surfactant: influence of variations in the phospholipid profile.

Authors:  M L Wilsher; D A Hughes; P L Haslam
Journal:  Clin Exp Immunol       Date:  1988-07       Impact factor: 4.330

4.  Decreased phosphatidylcholine in the lung fluid of patients with sarcoidosis.

Authors:  R P Baughman; S Strohofer; M Dohn
Journal:  Lipids       Date:  1985-07       Impact factor: 1.880

5.  The pulmonary surfactant: impact of tobacco smoke and related compounds on surfactant and lung development.

Authors:  J Elliott Scott
Journal:  Tob Induc Dis       Date:  2004-03-15       Impact factor: 2.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.